Related Experiment Video

Updated: May 25, 2026

On-Chip Endothelial Inflammatory Phenotyping
12:43

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

Interleukin-1β modulates smooth muscle cell phenotype to a distinct inflammatory state relative to PDGF-DD via

Matthew R Alexander1, Meera Murgai, Christopher W Moehle

  • 1Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia, USA.

Physiological Genomics
|February 10, 2012
PubMed

Insights

Interleukin-1β (IL-1β) induces a distinct inflammatory smooth muscle cell (SMC) phenotype via NF-κB, unlike platelet-derived growth factor-DD (PDGF-DD). This suggests unique markers like CCL20 for inflammatory SMCs in atherosclerosis.

Area of Science:

  • Vascular Biology
  • Cellular Phenotypic Modulation
  • Atherosclerosis Pathogenesis

Background:

  • Smooth muscle cells (SMCs) in atherosclerosis undergo phenotypic modulation, affecting differentiation, proliferation, migration, and matrix synthesis.
  • Inflammatory cytokines like Interleukin-1β (IL-1β) can induce inflammatory gene expression and repress SMC differentiation markers.

Purpose of the Study:

  • To test if IL-1β induces a distinct inflammatory SMC phenotype compared to PDGF-DD.
  • To elucidate the molecular mechanisms underlying IL-1β- and PDGF-DD-mediated SMC modulation.

Main Methods:

  • Genome-wide gene expression analysis of SMCs treated with IL-1β or PDGF-DD.
  • NF-κB pathway inhibition experiments.
  • Immunofluorescent staining of atherosclerotic mouse lesions.

Main Results:

  • Both IL-1β and PDGF-DD repressed SMC differentiation markers, but IL-1β induced inflammatory genes while PDGF-DD induced proliferation genes.
  • IL-1β-induced inflammatory gene expression and SMC marker repression were NF-κB dependent; PDGF-DD effects were not.
  • CCL20 was identified as a marker for IL-1β-stimulated inflammatory SMCs, while RGS17 marked PDGF-DD-induced proliferative SMCs in vivo.

Conclusions:

  • IL-1β induces a distinct inflammatory SMC phenotype characterized by NF-κB-dependent inflammatory gene activation.
  • PDGF-DD promotes a proliferative SMC phenotype independent of NF-κB.
  • CCL20 and RGS17 may serve as in vivo markers for distinct SMC states in atherosclerosis.

More Related Videos

Isolation of Primary Myofibroblasts from Mouse and Human Colon Tissue06:59

Isolation of Primary Myofibroblasts from Mouse and Human Colon Tissue

Published on: October 12, 2013

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...